Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers.

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers.

METHODS: A novel, fully bacterially produced recombinant virus-like particle (VLP) based influenza vaccine (gH1-Qbeta) against A/California/07/2009(H1N1) was tested in a double-blind, randomized phase I clinical trial at two clinical sites in Singapore. The trial evaluated the immunogenicity and saf...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ:	Low, J, Lee, L, Ooi, E, Ethirajulu, K, Yeo, P, Matter, A, Connolly, J, Skibinski, D, Saudan, P, Bachmann, M, Hanson, B, Lu, Q, Maurer-Stroh, S, Lim, S, Novotny-Diermayr, V
Ձևաչափ:	Journal article
Լեզու:	English
Հրապարակվել է:	2014

Նմանատիպ նյութեր

First‐in‐Human, Healthy Volunteers Integrated Protocol of ETC‐206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug
‌: Vincenzo Teneggi, և այլն
Հրապարակվել է: (2020-01-01)

Induction of human T-cell and cytokine responses following vaccination with a novel influenza vaccine
‌: Skibinski, D, և այլն
Հրապարակվել է: (2018)

Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.
‌: Schmitz, N, և այլն
Հրապարակվել է: (2009)

Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine
‌: Skibinski, D, և այլն
Հրապարակվել է: (2013)

Enhanced apoptotic activity of a structurally optimized form of galectin-1.
‌: Bättig, P, և այլն
Հրապարակվել է: (2004)

Mutations I117V and I117M and Oseltamivir sensitivity of pandemic (H1N1) 2009 viruses
‌: Hurt, Aeron, և այլն
Հրապարակվել է: (2013)

Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.
‌: Lamberto Manzoli, և այլն
Հրապարակվել է: (2011-01-01)

Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites
‌: Sirota Fernanda L, և այլն
Հրապարակվել է: (2009-05-01)

Mutations I117V and I117M and Oseltamivir Sensitivity of Pandemic (H1N1) 2009 Viruses
‌: Aeron C. Hurt, և այլն
Հրապարակվել է: (2012-01-01)

Factors influencing the uptake of 2009 H1N1 influenza vaccine in a multiethnic Asian population
‌: Wong, L.P., և այլն
Հրապարակվել է: (2010)

Emergence of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus within 48 Hours
‌: Masafumi Inoue, և այլն
Հրապարակվել է: (2010-10-01)

OA05-01. <it>In vivo </it>electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers
‌: Park H, և այլն
Հրապարակվել է: (2009-10-01)

Cytokine production by peripheral blood cells following therapy with a combined vaccine of allergen and QbG10
‌: Manolova, V, և այլն
Հրապարակվել է: (2008)

Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine.
‌: David A G Skibinski, և այլն
Հրապարակվել է: (2013-01-01)

Safety and Immunogenicity of the malaria vaccine candidate R21 adjuvanted with matrix-m1 in West African adult volunteers, Burkina Faso
‌: Tiono, AB, և այլն
Հրապարակվել է: (2017)

Addition of glycosylation to influenza A virus hemagglutinin modulates antibody-mediated recognition of H1N1 2009 pandemic viruses
‌: Job, Emma R., և այլն
Հրապարակվել է: (2013)

A universal Influenza A vaccine based on M2 mediates complete protection from lethal infection in mice
‌: Schmitz, N, և այլն
Հրապարակվել է: (2007)

Comparing the immunogenicity of AS03-adjuvanted 2009 pandemic H1N1 vaccine with clinical protection in priority risk groups in England.
‌: Chee-Fu Yung, և այլն
Հրապարակվել է: (2013-01-01)

Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients.
‌: João L Miraglia, և այլն
Հրապարակվել է: (2011-01-01)

Factors influence the uptake of 2009 H1N1 influenza vaccine in a multiethnic Asian population
‌: Wong, Li-Ping, և այլն
Հրապարակվել է: (2010)

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity.
‌: Maurer, P, և այլն
Հրապարակվել է: (2005)

HIV-1 Glycopeptides as Immunogens
‌: Hauser Steven, և այլն
Հրապարակվել է: (2005-12-01)

In vivo targeting of HIV gag to dendritic cells in combination with poly ICLC is safe and immunogenic in healthy volunteers
‌: Caskey M, և այլն
Հրապարակվել է: (2012-09-01)

Immunograph-based analysis of the influenza a(H1N1)pdm09 vaccine strain immunogenicity in the pandemic and post-pandemic period (2009–2014)
‌: V. S. Vakin, և այլն
Հրապարակվել է: (2021-12-01)

Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male Volunteers
‌: Yingzi Cui, և այլն
Հրապարակվել է: (2021-06-01)

Salivary gland antigens of laboratory-bred Phlebotomus sergenti and their immunogenicity in human volunteers in laboratory condition
‌: Arshad Veysi, և այլն
Հրապարակվել է: (2020-01-01)

Isolation of human monoclonal antibodies by mammalian cell display.
‌: Beerli, R, և այլն
Հրապարակվել է: (2008)

Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in a ferret model
‌: Guarnaccia, Teagan, և այլն
Հրապարակվել է: (2014)

Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model.
‌: Teagan Guarnaccia, և այլն
Հրապարակվել է: (2013-01-01)

NK1 receptor antagonism and emotional processing in healthy volunteers.
‌: Chandra, P, և այլն
Հրապարակվել է: (2010)

Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.
‌: Catherine A Cosgrove, և այլն
Հրապարակվել է: (2016-01-01)

Evaluation of immunogenicity of the 2008-2009 seasonal influenza vaccines by microneutralization test
‌: Seung Youn Kim, և այլն
Հրապարակվել է: (2012-12-01)

Corrigendum: Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male Volunteers
‌: Yingzi Cui, և այլն
Հրապարակվել է: (2022-05-01)

Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 Immunogens
‌: Emmanuel Margolin, և այլն
Հրապարակվել է: (2019-10-01)

CLINICAL STUDIES OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF LIVE MONOVALENT INFLUENZA VACCINE (STRAIN А/17/CALIFORNIA/2009/38 — H1N1) IN CHILDREN
‌: D.S. Bushmenkov, և այլն
Հրապարակվել է: (2010-07-01)

CLINICAL STUDIES OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF LIVE MONOVALENT INFLUENZA VACCINE (STRAIN А/17/CALIFORNIA/2009/38 — H1N1) IN CHILDREN
‌: D.S. Bushmenkov, և այլն
Հրապարակվել է: (2010-01-01)

Nanoparticles target distinct dendritic cell populations according to their size
‌: Manolova, V, և այլն
Հրապարակվել է: (2007)

2009:1
‌: N/A N/A
Հրապարակվել է: (2013-05-01)

Limited in vivo reactivity of polyclonal effector cytotoxic T cells towards altered peptide ligands.
‌: Bättig, P, և այլն
Հրապարակվել է: (2005)

Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteers.
‌: Sanjay Mehendale, և այլն
Հրապարակվել է: (2013-01-01)